Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Jesse M. Cedarbaum is Vice President of Clinical Affairs at Regeneron Pharmaceuticals, Inc., and Clinical Associate Professor of Neurology at Mount Sinai Medical School. His expertise includes clinical research, biostatistics, regulatory affairs, clinical pharmacology and pharmacokinetics and toxicology. His areas of clinical research interests and activities have included Parkinson's disease, amyotrophic lateral sclerosis, peripheral neuropathy, and retinal degenerative disorders. Prior to joining Regeneron in 1990, Dr. Cedarbaum was Director of the Parkinson's Disease and Movement Disorder program at New York Hospital-Cornell Medical Center in New York, and the Burke Rehabilitation Center in White Plains, NY, and Associate Clinical Professor of Neurology at Cornell Medical School from 1983 to 1990. Dr. Cedarbaum received his B.A. and M.A. from Stanford University and his M.D. from Yale Medical School.
Neuromuscular disorders ,neurology, Alzhemeirs disease, Neuro rehabilitation,Parkinsons disease
Diane Stephenson, Martha Brumfield, Klaus Romero, Janet Woodcock, Issam Zineh, Eric M Reiman, Caroline Tanner, Richard Mohs, Walter Koroshetz, Timothy Nicholas, Lisa J Bain, Derek Hill, Les Shaw, Johan Luthman, Michael Ropacki, Richard Meibach, Peter Loupos, Ken Marek, James Hendrix, Eric Karran, George Vradenburg, Keiju Motohashi, Jesse M Cedarbaum and Mark Forrest Gordon
Conference Proceeding: J Alzheimers Dis Parkinsonism 2015, 5:183
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals